Episoder

  • Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor and entrepreneur focused on accelerating much improved future of health and biomedicine at the convergence of accelerating technologies and human innovation. He is the founder of NextMed Health & Digital.Health, Chairs the XPRIZE Health Alliance, and is a sought after speaker on the future of medicine, with 6 TED & TEDMED Talks.  
    Join NextMed Health in December 2024 in San Diego: https://www.nextmed.health/

    In this discussion, Daniel talks about: 
    - Basic Health Practices: The importance of sleep, diverse food, exercise, and social connections as foundational health practices, alongside high-tech tools.
    - Longevity vs. Healthspan: The discussion shifts from living longer (longevity) to improving the quality of life in later years (healthspan), through proactive health measures.
    - Behavior Change is Key: Digital health innovations, while advanced, still face challenges in encouraging sustained behavior change, which is crucial for better health outcomes.
    - Generative Health and Personalization: The concept of "Generative Health" is introduced, where AI-based health coaches personalize advice based on individual preferences, genetics, and lifestyle.
    - AI in Healthcare: AI's most immediate impact will likely be in administrative areas, reducing burnout by automating tasks and helping clinicians focus on more critical decisions.
    - Hospital-to-Home Care: The shift from hospital care to home care (or "homespital") is a major trend, driven by advances in remote monitoring, telehealth, and AI-based triage systems.
    - Barriers to Digital Health: Regulatory, cultural, and business model barriers continue to impede the full integration of digital health solutions, despite technological advancements.
    - Future of Healthcare Delivery: As healthcare moves towards more home-based care, the infrastructure and training for clinicians must evolve to support this shift effectively.
    - AI and Ethical Considerations: There is a need to balance the use of AI in healthcare with maintaining human cognitive abilities, ensuring clinicians remain skilled in diagnosis without over-reliance on technology​

    facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

  • This episode features Dr. Chelsea Sumner discussing NVIDIA's significant role in healthcare, particularly in its work with AI startups. Key areas of focus include NVIDIA’s contributions to medical imaging, genomics, and drug discovery, and its innovative tools like Clara and NIMs. The conversation highlights how NVIDIA collaborates with startups, its global footprint, and insights into AI’s transformative potential in healthcare.
    Key Points:

    NVIDIA’s Role in Healthcare:


    GPUs in Healthcare: NVIDIA's graphics processing units (GPUs) power AI and are pivotal in medical imaging, genomics, and drug discovery.


    Clara Platform: A suite of healthcare-focused AI tools supporting genomics (Parabricks), medical imaging (Moni), robotics (Isaac), and drug discovery (BioNemo).

    Collaboration with Startups:


    Inception Program: NVIDIA supports over 3,000 healthcare startups globally, offering them tools, resources, and access to venture capital (VCA).


    Diverse Startup Sizes: Startups range from small two-person teams to large-scale companies with 800+ employees.


    Examples of Partnerships:


    Mendel AI: Improved deployment efficiency by 75% using NVIDIA’s Inference Microservices (NIMs).


    Hippocratic AI: Developing empathetic AI avatars for patient interactions.


    Abridge: AI-powered clinical conversations that can generate clinical notes, saving clinicians time.

    What Are NIMs?


    NIMs (NVIDIA Inference Microservices): These microservices streamline AI model deployment, enabling faster and easier integration of AI models into applications.

    Key Healthcare Innovations:


    Genome Sequencing: NVIDIA set a world record for genome sequencing in under 6 hours, highlighting advancements in personalized medicine.


    GI Genius with Medtronic: AI-assisted colonoscopy tool leveraging NVIDIA’s technology to detect polyps, aiding in colorectal cancer prevention.


    J&J MedTech Collaboration: Connecting digital ecosystems for surgery to provide real-time insights to medical professionals.

    Global Healthcare Impact:

    NVIDIA operates in healthcare ecosystems worldwide, collaborating with startups and partners in North and Latin America, Europe, China, and APAC regions.

    Their technologies are integrated with global academic medical centers, research institutions, and conferences like RSNA and Health U.S.


    Future of AI in Healthcare:


    Digital Biology, Surgery, and Health: Key areas where generative AI will impact healthcare, from diagnostics to personalized treatment.


    Model Transparency (Model Cards): NVIDIA’s trustworthy AI initiatives include model cards, which offer transparency into AI models' development and data, aiding in mitigating bias.



    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

  • Mangler du episoder?

    Klikk her for å oppdatere manuelt.

  • This episode gives an in-depth insight into healthcare digitalization in Portugal. Cátia Sousa Pinto, Head of Global Digital Health and International Affairs at SPMS - shared services of ministry of health of Portugal talked about healthcare digitalization in Portugal, European Health Data Space (EHDS), patient data and more.

    Key Points Summary


    Portugal's Digital Health System Design: To accelerate digital health development, Portugal created a national eHealth agency (SPMS) over a decade ago.


    SPMS Role: SPMS plays a dual role, not only regulating but also developing and maintaining ICT solutions for Portugal's healthcare system. This centralization helps prevent fragmentation and ensures interoperability.


    European Health Data Space (EHDS): EHDS is the EU's regulatory framework for cross-border health data sharing, building on initiatives like MyHealth@EU. The goal is to allow seamless healthcare across Europe, where any EU citizen can access healthcare in other countries as if they were at home.


    My Health at EU: A foundational initiative that enables cross-border exchange of health data like patient summaries and e-prescriptions between EU countries.


    Patient Data: Catia emphasized the importance of patients controlling their health data and being able to share it across healthcare providers. This includes e-prescriptions, laboratory results, and, eventually, medical images.


    Portugal's National Electronic Health Record: A key project for the country is the creation of a unified electronic health record system, allowing citizens to access all of their health data, both public and private, from a single source.


    Use of EU Funding: Portugal has allocated €300 million from the EU's recovery funds for digital health transformation, focusing on infrastructure, citizen-centric services, and reducing the burden on healthcare professionals.


    Challenges and Future Outlook: The integration of digital health into national governance and improving interoperability between systems remain ongoing challenges. Katia stressed the importance of moving towards real-time, structured health data to improve future healthcare outcomes.


    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/


    Show notes:
    [00:02:00] - Overview of Digital Health in Portugal
    [00:06:00] - National-Level Initiatives and Successes
    [00:10:00] - European Health Data Space (EHDS) and My Health at EU
    [00:16:00] - Cross-Border Care and Digital Infrastructure
    [00:20:00] - The Role of SPMS in Portugal’s Digital Health Journey
    [00:30:00] - Challenges and Workforce Management in Digital Health
    [00:34:00] - Benefits of Centralization in Small Countries
    [00:38:00] - Electronic Health Records and Expanding Digital Services, Secondary use of data [00:42:00] - Portugal’s National Electronic Health Record
    [00:46:00] - Future Vision for Health Data Integration

  • In this episode Anne Forsyth, Director of Clinical Applications and Support at Women’s College Hospital in Canada, discusses the challenges and opportunities in optimizing healthcare IT systems, particularly in data management and digital literacy. She shares her experiences transitioning from a policy role to a hospital setting and emphasizes the importance of data governance, workflow design, and continuous improvement in digital health projects.
    Key Takeaways:

    Community and Collaboration: Canada’s digital health community is a significant asset in advancing healthcare IT.


    AI and Data Standards: The adoption of AI in healthcare is promising but requires robust data governance and standards.


    Importance of Fundamentals: Good governance, workflow optimization, and training are crucial in creating sustainable healthcare IT systems.


    Digital Health Literacy: Clinicians need focused training on using digital tools correctly rather than deep technical knowledge.


    Cybersecurity Preparedness: Hospitals must prioritize business continuity planning to prepare for potential cyber attacks.


    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/
    Show notes:
    [00:04:00] Optimism in Canadian Digital Health
    [00:06:00] The Role of AI and Data Standards
    [00:08:00] Transition from Policy to Practice
    [00:10:00] The Fundamentals of IT in Healthcare
    [00:16:00] Tackling Unstructured Data
    [00:22:00] Continuous Improvement in Healthcare IT
    [00:26:00] Digital Health Literacy for Clinicians
    [00:34:00] Cybersecurity and Business Continuity
    [00:38:00] Closing Remarks and Advice

    The importance of strong relationships with vendors and clinicians in solving technical challenges in healthcare IT.

    Final thoughts on the continuous nature of digital health optimization and the need for sustainable, well-communicated strategies.

  • In healthcare, consultants are present more often than we might realise: they work with healthcare providers to improve clinical efficiency, manage costs, implement new technologies, or streamline administrative processes. They can help with regulatory compliance, help insurance companies design new poducts, governments hire them to help with policy development, program evaluation, and implementation of new regulations. 
    In this episode we take a look under the hood of consultancy work, where governments make biggest mistakes and how consultants approach problem-solving.
    Mehdi Khaled is Internal Medicine Doctor and Fortune 50 Health Tech Executive, with over 25 years of international experience. He has helped shaping many large-scale, transformative digital health projects across four continents and within 40 health systems. As a Managing Partner at Seha, he specializes in developing and executing cutting-edge health and digital health strategies, with a strong emphasis on the meaningful use of data to drive health system improvements.

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

    Topics covered:

    00:04 - The Role of Consultants in Healthcare
    00:06 - Challenges of Accountability
    00:08 - Core Principles for Healthcare
    00:10 - Singapore’s Healthcare Success
    00:12 - Implementing Technology in Healthcare
    00:14 - The Balance Between Technology and Clinical Needs
    00:16 - The Importance of Clinical Engagement
    00:18 - Managing Technology in Healthcare
    Exploration of the concept of "management debt," where poor decision-making leads to the accumulation of ineffective technologies.
    00:20 - Cultural Differences in Healthcare
    00:22 - Bridging the Knowledge Gap in Digital Health
    00:24 - Case Studies and Real-World Examples
    00:26 - The Need for Long-Term Vision
    00:28 - Lessons from Singapore and Catalonia
    00:30 - Technology-Driven Change in Healthcare
    00:32 - Overcoming Barriers to Innovation
    00:34 - The Future of Digital Health
    00:36 - Building Local Capacity
    00:38 - Avoiding Dependency on Consultants
    00:40 - Final Thoughts on Healthcare Consulting

  • Catalonia published a new digitalization strategy in 2017. It set a new path of the healthcare IT infrastructure, based on open-platform approach, focusing on data persistence with the use of openEHR data specification.

    In this discussion, you will hear from Jordi Piera Jiménez, Director of the Digital Health Strategy Office at the Catalan Health Service and Director at openEHR International, representing organisational members.
    He discussed specifics of the Spanish healthcare market, how far Catalonia came since 2017, how is Catalonia building, using and updating a multi-morbidity scoring system for patients which enables easier clinical decision making, cybersecurity attacks and ultimate improvement in information security measures, and more.

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

  • Artur Olesch is Berlin-based journalist specializing in digital health, the founder of aboutDigitalHealth.com, and the editor-in-chief of ICT&Health International. In this discussion, he shares his thoughts on the European legislation of healthtech, his thoughts on most intriguing books in tech and AI, and more. 

    His 3 book picks: 
    Ray Kurzweil - Singularity is nearer 
    Ethan Mollick - Co-Intelligence: Living and Working with AI
    Philip E. Tetlock, Dan Gardner - Superforecasting: The Art and Science of Prediction

    Show notes:
    03:00 About Ray Kurzweil - Singularity is nearer 
    10:00 Ethical use of healthcare data - how sharing is connected to democratic values 
    14:00 Data analytics and data use examples and inspiration
    17:00 DiGA in the field: do doctors know it 
    18:45 Approach to behavioral health improvement and the role of digital
    20:00 Book 2: Ethan Mollick - Intelligence 
    22:58 Predicting disease - yes or no? 
    26:00 Best insights from conference, top topic: ambient intelligence systems 
    35:00 Hopes and fears about the future of healthcare digitalization

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

  • John Halamka is the President of the Mayo Clinic Platform and a leading expert in digital health and AI. He has traveled to 21 countries, helping to scale digital health solutions and address regulatory and ethical challenges in the reuse of healthcare data.

    Addressed topics in this discussion:
    1. Differences in regulatory frameworks and cultural expectations across countries.
    2. Comparison of the U.S. and European approaches to AI and data exchange.
    3. Risks associated with generative AI and the need for a credibility scores.
    4. Observations from various countries on AI adoption. Importance of local tuning for algorithm validation.
    5. Data Standards and Future Trends.
    6. Advice for Governments and Healthcare Institutions: Encouraging a proactive approach to AI adoption -Starting with low-risk projects and building trust and reliability.

    Website: www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/
    Youtube: https://www.youtube.com/watch?v=tH9qYpFW-W8

  • You may not have heard about Prenuvo, but you probably know Kim Kardashian. Or perhaps you know about Prenuvo because of Kim Kardashian.
    Prenuvo offers whole-body MRI scans for $2500. About 3-4% of people get something discovered, 10% have detected changes that require follow-ups.
    Opinions about the usefulness of these scans are diverse, with some hesitation on the clinical side.

    At HLTH Europe, the CEO Andrew Lacy explained:
    🤔 How Prenuvo uses influencer marketing to attract new customers,
    🤔 whole-body MRI scans in light of other preventive whole-body scans and the emerging field of liquid biopsies,
    🤔 affordability/ scans as a status symbol,
    🤔 the future of prevention,
    ... and more.
    www.facesofdigitalhealth.com
    Newsletter: fodh.substack.com

  • If you ever want to go to a healthcare innovation conference that doesn’t shy away from potentially controversive topics, HLTH is your place to go. In June 2024, the conference, which attracts 12,000 people in the US, came to Europe. At the center of the exhibition hall stood the Heart Stage focused on topics related to women’s health. Around it were the exhibitor booth and other stages, each designed with a different theme, each like a theatre setup that made speakers feel like stars. Why do people love going to HLTH? Because it’s focused on the experience of the attendees in “a little extra” way. The ticket includes meals, music, there were massage and hair salon in the middle of the exhibition floor, lots of evening networking events, from more formal but still unusual ones, such as the Phillips reception in a museum, to the closing evening with a concert by The Libertines. When the experience is good, and festival-live, it attracts people. When people come, you very quicky attract VIPs of the industry, who many hope to meet and do business with. Win win. In this episode, you will hear impressions and insights from speakers and attendees of the event. You will hear about: partnerships and investment in Europe, women’s health, the German market, what companies don’t understand about patient engagement, and AI. 
    Speakers:


    John Halamka, President of Mayo Clinic Platform,


    Sara Schmachtenberg, Digital Health Venture Expert / Head of Data and Analytics, Europe & USA at Galen Growth,


    Simon Phillip Rost, the Chief Marketing Officer at GE Healthcare,


    Jen Horonjeff, PhD, Founder and CEO of Savvy Cooperative, and Ronnie Sharpe, co-founder and COO at Savvy Cooperative,


    Christophe Jauquet, Author & Professional Keynote Speaker on how business & technology shape a healthier, happier, more sustainable future.

     Dorothée Marie-Louise Doepfer, Deputy Head of Digital Labs / Program Management Digital Health Accelerator & Community Building & Co-organizer Berlin Institute of Health at Charité.


    www.facesofdigitalhealth.com
    Newsletter: fodh.substack.com

  • Debates around equity and equality, especially concerning men and women and female representation, can become heated and divisive quickly.
    For a long time, female bodies have been perceived merely as male bodies with different reproductive organs. However, the differences go beyond that: 80% of people with autoimmune conditions are women, 66% of Alzheimer's disease patients are women, and symptoms of cardiovascular diseases present differently in women and men, among other disparities. These health issues significantly impact women's productivity.
    In today's episode, you will hear a recording from the Healthcare Business Women Ljubljana meetup focused on women's health.
    Joy Rios, founder of HIT Like a Girl Media joined the discussion on women's health and how the unique aspects of women's health are impacting digital health companies and businesses. While less than a quarter of CEOs in digital health companies are women, in femtech companies, 76% of founders, co-founders, and CEOs are women.

    Website: www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

    Show notes:
    [00:02:00] Guest Speaker: Joy Rios
    [00:03:00] Current State of Women's Health

    Common associations with women's health: menstrual health apps (Clue), pelvic floor training (Elvie), sexual health (Rosy).

    Innovations in women’s health: apps for sexual assault victims, and addressing menopause and ovarian health.

    [00:04:00] Research and Development

    Only 4% of R&D budgets historically went into women's health topics.

    Inclusion of women in clinical trials has improved, but gaps remain in medical device trials.

    [00:05:00] Challenges and Biases
    [00:06:00] Policy and Investment
    White House initiative and Melinda French Gates’ $2 billion investment in removing barriers for women.
    [00:16:00] Impact of Abortion Rights on Women's Health

    Roe v. Wade overturned, affecting access to abortion and impacting startups in the field.

    Differences in state laws create challenges in providing consistent healthcare.

    [00:22:00] Inspiring Developments

    Policy changes in Mexico leading to increased female representation in politics.

    Mexico’s progressive stance on women in leadership positions.

    [00:26:00] Advice for Women in Healthcare Business

    Identify unique opportunities and unmet needs in healthcare.

    Understand regulations and compliance.

    Build a supportive community and collaborate.

  • Rome was buzzing with digital health at the end of May as the HIMSS Europe conference took place at La Nuova Congress Center. Delegates from 80 countries and representatives of health ministries of 20 countries marked the event with discussions about the implementation of EHDS, the EU AI Act, and more. 
    In this episode, a few participants share their impressions from the discussions at the conference and the current state of healthcare digitalization in Europe.
    You will hear from: 

    Jordi Piera-Jiménez. Director of the Digital Health Strategy Office, Catalan Health Service, who shared his view and experience on data management and data standards, 

    Rachel Dunscombe , CEO of openEHR foundation and former the UK AI council member leading on AI in digital health and care, who presented the discussions on AI,

    Svava María Atladóttir, Executive Director of Development, Landspítali National University Hospital Iceland, about what it takes to build a new hospital which is what she needs to do by 2030, 

    Nana Odom, Director of Clinical Engineering at the Cleveland Clinic in London, who shared her advice for clinical engineers,

    Diana van Stijn, Chief Medical Officer and co-founder of Lapsi Health and resident of Pediatrics at UMC Amsterdam, who talked about the doctor’s perspective on the use of tech and upskilling, 

    Luke Evason, Consultant and Monica Kleiijn Evason, Leadership Coach and Book Author, who both talked about the patient perspective on gaps in healthcare, particulary at the transfer of children going from pediatric to adult care. 


    Data quality is key for quality AI, another big topic globally, with regulation outlined in Europe with the EU AI Act. Where are discussions in healthcare? The EU AI Act is here, and discussions now resolve around implementation and technical questions. 
    The potential of data is huge… if the data is of good quality. This doesn’t only refer to clinical notes doctors input in electronic health records, but also how other data from devices, laboratories and more flows into EHR. Oftentimes, hospitals still battle with lack of interoperability and manual transcriptions between systems or from devices for vital signs, infusions pumps, etc. to clinical systems. This creates opportunities for errors. Hospitals that have all the systems connected, need to be mindful of other challenges. Cybersecurity went well beyond teaching employees to spot phishing email. Now, third party devices can pose a cybersecurity risk, creating a whole new set of challenges and requirements.
    Care delivery is there for patients. Various topics were addressed at HIMSS about patients - from digital health literacy, concerns and hopes around the European health data space, there was an interoperability showcase on the showfloor which demonstrated the benefits of the European Patient Summary when patients travel abroad, of the impact of cross-border health that gives clinicians in regions outside patient’s residence valuable information about their health state. Many things are still missing though. One of them being improved patient journey, especially at the transit from pediatric to adult care.

    Newsletter: https://fodh.substack.com/
    www.facesofdigitalhealth.com

  • According to WHO, the global cost associated with medication errors is 42 billion US dollars. Errors can happen at the point of prescribing, transcribing from one system to the other, or administration, when the wrong patient is given either the wrong drug or the wrong dose. Medication administration errors can be prevented with the introduction of closed-loop medication management, where all points of medication handling are connected and done electronically; even medication administration is done with the help of barcode scanning of the patient barcode and medication barcode. Three European specialists from the Netherlands, UK, and Belgium recently started a European project, Asclepius, which advocated for the introduction of closed-loop medication management systems in the hospitals. They connected with colleagues from UK, France, Iceland, Belgium, Norway, Netherlands, Sweden to strive for alignment on the European level. So in today’s discussion, you will hear from Patrick van Oirschot, Patrick Koch and Francine de Stoppelaar talk about the need for improved medication safety.

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

    Show notes:
    Main Discussion:
    [00:01:00] Medication administration errors can be prevented with the introduction of closed-loop medication management, where all points of medication handling are connected electronically.

    Guest Introductions:

    [00:04:00] Patrick van Oswalt ("Pat"), a veteran in hospital pharmacy with a focus on digitalization and closed-loop medication management strategies.

    [00:05:00] Francine de Stoppelaer, a clinical pharmacist with a 25-year career in healthcare leadership, notably involved in building and operating the Cleveland Clinic London.

    [00:06:00] Patrick, with a background in medical imaging and pharmacy automation, emphasizes the need for digital transformation in hospital pharmacies.

    Challenges and Solutions:

    [00:08:00] Discussion on medication safety across Europe, highlighting the significant number of medication errors and associated costs. Specific examples include 19,000 deaths per year in Germany due to medication errors.

    [00:10:00] Explanation of closed-loop medication management and barcode scanning at the bedside to ensure the right medication reaches the right patient.

    [00:14:00] Different approaches to medication management in various countries, focusing on the importance of digital and automated processes.

    Implementation Strategies:

    [00:16:00] Discussion on where hospitals should start when considering digital transformation for medication safety, highlighting the importance of electronic prescribing and bedside scanning.

    [00:18:00] The experience of implementing a fully digital hospital at Cleveland Clinic London, including workforce planning and gaining buy-in from healthcare professionals.

    Project Overview:

    [00:20:00] Introduction to the Asclepius project and its goals to harmonize medication management workflows across Europe.

    [00:22:00] Highlighting the need for standardization in medication databases and the varying approaches to medication management across different countries.

    Impact and Future Directions:

    [00:24:00] The potential impact of digital and automated medication management on patient safety, efficiency, and sustainability.

    [00:26:00] Encouraging adoption of best practices and the importance of measuring and monetizing the benefits of closed-loop systems.

    [00:28:00] Challenges in convincing decision-makers and ensuring effective implementation amidst existing workloads.

  • The European Health Data Space is around the corner. The legislation is confirmed. How do we get to the next steps? Today you will hear a discussion with Eric Sutherland, Senior Health Economist and Digital Health Lead at OECD, who worked on the pan-Canadian health data strategy before his current role. We discussed the upcoming implementation of the European Health Data Space, what needs to happen next, how do we involve the public, encourage trust in data sharing, and also build capacity for digital health implementation. We are moving into the era of new required data professionals, not just data analysts, but also data controllers, data stewards and more. 

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

    Show notes:
    [00:02:00] - Eric Sutherland's background and transition from Canada to OECD
    [00:04:00] - Challenges and solutions in Canadian health data strategy, emphasizing the need for data stewardship and public engagement
    [00:06:00] - Importance of data interoperability and policy compatibility across regions
    [00:08:00] - Goals of Canadian health data strategy and its impact, focusing on improving healthcare delivery through better data utilization.
    [00:10:00] - Governance and collective impact in Canadian healthcare
    [00:12:00] - European health data space and public engagement
    [00:14:00] - Opt-out provisions and public interest in European health data space
    [00:16:00] - Setting standards and policy compatibility in Europe
    [00:18:00] - Learning from historical approaches in healthcare data strategies
    [00:20:00] - Digital health literacy and public engagement
    [00:22:00] - Simplifying communication in digital health
    [00:24:00] - Role of patient leaders and public deliberation in health policy
    [00:26:00] - Public expectations on health data usage
    [00:28:00] - Economics of digital health and ROI
    [00:30:00] - Utilizing health data for policy and research
    [00:32:00] - Interoperability and investment in digital health infrastructure
    [00:34:00] - Shifting towards a prevention-based health system
    [00:36:00] - Workforce and capacity building in digital health
    [00:38:00] - Automation and the future of health workforce

  • AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only about 20 percent of human coding genes are well-studied. The remaining 80 percent (about 16,000 genes, along with the proteins they make) are largely a mystery. 
    In this episode, you will hear more about the field of immuno-oncology, understand the correlation between tumor development and immune system response, and trends in cancer detection and prevention, especially liquid biopsies - tests for detecting tumors in blood samples. 
    Speaker: Brian Hashemi - Executive Chairman and CEO of Novigenix - a Swiss-based biotech company using AI and RNA sequence analysis to capture the cancer immunity cycle during the multi-stage disease progression and response to therapy.
    www.facesofdigitalhealth.com
    https://fodh.substack.com/

    Show notes:
    [00:02:00] The use of AI and RNA sequence analysis in capturing the cancer immunity cycle and disease progression
    [00:04:00] Biotech in Switzerland
    [00:06:00] The impact of Swiss biotech capabilities on global healthcare and the specific advancements made by Swiss companies in the field.
    [00:08:00] Predictions and hopes for the future of healthcare technology, especially in the realms of cancer detection and treatment.
    [00:10:00] Challenges and opportunities in biotech, and the role of AI in advancing healthcare.
    [00:12:00] Challenges in Colorectal Cancer Screening
    [00:14:00] The Impact of Liquid Biopsy on Clinical Trials and Drug Development
    [00:16:00] Market Adoption and Patient Accessibility to Liquid Biopsy Tests
    [00:18:00] The Future of Liquid Biopsy and Precision Medicine
    [00:20:00] Real-world Application and Impact of Novel Biomarkers
    [00:22:00] Expanding the Reach of Novel Diagnostics Beyond Switzerland
    [00:24:00] Partnerships and Collaborations to Accelerate Adoption

  • The Gulf Cooperation Council (GCC) brings together six Arab countries – Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates 
    When one reads about the GCC countries, there’s nothing but the impression of prosperity: high investments, determination, and enthusiasm in tech-supported healthcare. 
    The spending on healthcare by the GCC governments is on an astronomical rise. From a regionwide US$2.4 billion in 2016, it rose to more than US$30 billion in 2021 and is projected to surpass US$104 billion this year, according to a report from the UAE Ministry of Economy. 
    In this episode, Pilar Fernandez Hermida International Go-to-Market expert with 20+ years of experience launching sales & partner ecosystem strategies, talks about the potential of the Middle East and MENA region for healthtech companies, the culture in the Middle East, how to interpret different style of communication here, what are the common entrepreneurial misconceptions, and where to find opportunities. Pilar says that the entrepreneurial spirit here is 10-times as strong as in the US, and that biotech and drug development are the next thing to watch for in the region.


    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/
    Show notes:

    [00:02:00] Pilar Fernandez Hermida, an expert in healthcare market strategies, shares insights from Abu Dhabi.

    [00:04:00] Analysis of the healthcare infrastructure development in GCC post-pandemic.

    [00:08:00] The role of expats in the Middle East's healthcare transformation.

    [00:10:00] Public-private partnerships as key opportunities.

    [00:12:00] Cultural considerations for startups in the GCC.

    [00:14:00] Misconceptions about the Middle Eastern healthcare market.

    [00:18:00] Building long-term relationships in business.

    [00:20:00] Navigating diverse cultural communication in healthcare.

    [00:24:00] Comparing the entrepreneurial spirit in the Middle East with the U.S. and Europe.

    [00:28:00] Strategic advice for healthcare entrepreneurs targeting the GCC.

    [00:30:00] Importance of understanding regulations and digital maturity in MENA.

    [00:32:00] Future potential in biotech and digital health in the GCC.

    [00:36:00] The convergence of digital health and biotech.

  • In the last few years, we've witnessed a whirlwind of developments in the world of Digital Therapeutics (DTx) - from FDA approvals sparking optimism for the industry, to the establishment of regulatory frameworks in countries like Germany, France, and Belgium.
    However, in 2023, the industry faced a stark reality check, marked by the fall of some key players and healthcare systems' hesitancy towards embracing and financing these innovations. This turbulence has reshaped strategies and raised critical questions about the future of DTx.
    🔍 In this episode learn more about:
    📊 The current state of the DTx industry in 2024,
    🗣️ Key debates of digital therapies industry players,
    🌐 Advocacy efforts pushing the boundaries for global adoption,
    🚀 Strategies to accelerate the integration of digital therapies worldwide.

    Newsletter: fodh.substack.com
    Website: www.facesofdigitalhealth.com

  • Patient-reported outcomes (PROs) have become increasingly integral in healthcare for assessing the effectiveness of treatments from the patient's perspective. It sounds like a reasonable step in improving clinical research and care provision, but gathering data can be more difficult then you may think. It isn't easy to get to marginalized communities. There are language barriers in collecting data. There are cultural aspects that impact responses. So, how can you design useful electronic solutions for patient-reported outcomes? Hear from Mustafa Ali Syed, Researcher at the Manchester Academic Health Science Centre, The University of Manchester, and Ben James, Co-founder/Chief Design Officer at uMotif - ePRO, an engagement platform designed to power clinical and real-world research. Both are co-authors of a recently published paper titled Exploring the Cross-cultural Acceptability of Digital Tools for Pain Self-reporting.

    www.facesofdigitalhealth.com
    Newsletter: https://fodh.substack.com/

    Show notes:
    00:00:00 Why Do PROs Matter?
    00:04:00 Evolution of Data Collection
    00:06:00 Importance of Diversity in Clinical Trials
    00:08:00 Ethnicity, Culture, and Pain Perception
    00:12:00 The Role of Technology in PROs
    00:14:00 Designing Inclusive Digital Solutions
    00:20:00 Challenges in Engaging Targeted Populations
    00:22:00 Language and Communication Barriers
    00:26:00 The Future of PRO Research

  • Did you know that Belgium has had an idea for classifying and validating digital therapeutics since 2018? A clear framework was formed with all main stakeholders involved - from health insurance to the industry. So why are we not hearing more about DTx in Belgium? In this discussion you will hear from Dr. Steven Vandeput - he is the Advisor for Digital MedTech and Services & Technologies Home Assistance in Belgium; he is managing the mHealthBelgium portal and, since 2019, has been a representative for beMedTech, the sector federation that represents the industry of medical technologies in Belgium. Website: www.facesofdigitalhealth.comNewsletter: https://fodh.substack.com/Show notes: 00:00 - Introduction01:45 - Digital Therapeutics in Belgium03:50 - Belgium's Healthcare Framework Development06:00 - The Validation Pyramid and Reimbursement System08:00 - Fate of Pilot Projects and Their Impact10:00 - Utilization of mHealth Belgium Portal12:00 - Challenges in Reimbursement and Financing14:00 - Prospects for Digital Therapeutic Companies16:00 - Belgium's Approach to Financing Digital Health18:00 - Anticipations for the Digital Health Field20:00 - The Evolving European Frameworks22:00 - Impact of Political Decisions and Healthcare System Integration24:00 - The Future of mHealth Belgium Platform

  • The field of oncology treatments is advancing very fast with innovative therapies and approaches on the market every day. It can get very tricky to support these therapies from an IT perspective, which is what you will hear more about in this discussion. I spoke with Anish Patankar, SVP and GM of Elekta’s Oncology Software Solutions, and we discusses:

    How to go about the US hospital market, 

    Development in software for oncology treatments,

    Challenges in scaling healthcare IT software across markets. 


    Newsletter: https://fodh.substack.com/
    www.facesofdigitalhealth.com

    Show notes:
    [00:00:00] Introduction to Elekta
    [00:02:00] Elekta's Global Presence
    [00:04:00] US Market Focus
    [00:06:00] Growth in Developing Countries
    [00:08:00] Segmentation and Technology Adoption in the US
    [00:10:00] Untapped Needs and Opportunities in the US
    [00:12:00] Elekta's Use of AI
    [00:14:00] Patient Feedback and Clinical Decision Making
    [00:18:00] Navigating Legacy Software in Healthcare IT
    [00:20:00] Modernization and Customer Satisfaction
    [00:22:00] Global Standardization and Regulation Challenges
    [00:24:00] Interoperability and Open Ecosystem
    [00:26:00] Future of Oncology Market Development: the interplay between medications and radiation, and the potential of theranostics.
    [00:28:00] Exciting Technologies in Healthcare Beyond Oncology: personalized healthcare, digital twins
    [00:30:00] Cautions for the Future: The critical debate on the balance between innovation speed and safety, particularly with generative AI.